Rondo Therapeutics

Series-A
rondotx.com Biotech & Healthcare Hayward, United States Founded 2021 11-50
Total Funding $67M
Latest Round $67M Series-A
Last Announced Mar 2, 2022
Investors 5 Backers
Decision Makers 4 Verified

About Rondo Therapeutics

We are committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Hayward, United States
Year Founded 2021
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website rondotx.com
Domain Registered Date Jun 3, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $67,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    rondotx.com

  3. Milestone

    Company founded

    Hayward, United States

Investors & Backers

5
Canaan Partners
Johnson & Johnson Innovation
Novo Holdings
Red Tree Venture Capital
SV Health Investors

Funding History

1 Round
Series-A · Mar 2, 2022

Founders & Leadership

2

Nathan Trinklein

Chief Scientific Officer | Co-Founder

Work email & phone locked Unlock →

Shelley Force Aldred

Chief Executive Officer | Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts